Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
World Journal of Urology
|
August 27, 2018
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis
Niall F Davis, G S Jack, W P Witjes, et al.
Neurourology and Urodynamics
|
March 26, 1998
Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study
J J de la Rosette, W P Witjes, W Schäfer, et al.
The Journal of Urology
|
April 1, 1997
The International Continence Society "Benign Prostatic Hyperplasia" Study: international differences in lower urinary tract symptoms and related bother
W P Witjes, J J de la Rosette, J L Donovan, et al.
The Journal of Urology
|
April 1, 1996
A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer
F M Debruyne, G A Dijkman, D C Lee, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
World Journal of Urology
|
August 27, 2018
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis
Niall F Davis, G S Jack, W P Witjes, et al.
Neurourology and Urodynamics
|
March 26, 1998
Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study
J J de la Rosette, W P Witjes, W Schäfer, et al.
The Journal of Urology
|
April 1, 1997
The International Continence Society "Benign Prostatic Hyperplasia" Study: international differences in lower urinary tract symptoms and related bother
W P Witjes, J J de la Rosette, J L Donovan, et al.
The Journal of Urology
|
April 1, 1996
A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer
F M Debruyne, G A Dijkman, D C Lee, et al.
Page
of 5